Shares of Cerulean Pharma Inc. (NASDAQ:DARE) have been assigned a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and three have issued a buy recommendation on the company. […]
